Novel CERKL variant in consanguineous Jordanian pedigrees with inherited retinal dystrophies |
| |
Authors: | Belal Azab Raghda Barham Dema Ali Zain Dardas Lana Rashdan Maysa Bijawi Ranad Maswadi Abdelhalim Awidi Hanan Jafar Mohammed Abu-Ameerh Muawyah Al-Bdour Sami Amr Abdalla Awidi |
| |
Affiliation: | 2. Clinical Laboratory Sciences Department, School of Science, The University of Jordan, Amman, Jordan;3. London School of Hygiene and Tropical Medicine, London, United Kingdom;4. Ophthalmology Department, Jordan University Hospital, The University of Jordan, Amman, Jordan;5. Department of Medicine and Hematology, Jordan University Hospital, The University of Jordan, Amman, Jordan. |
| |
Abstract: | ObjectiveTo identify the disease-causing variants in 2 families with autosomal recessive inherited retinal dystrophies (IRDs) and to characterize phenotypic variability across the affected family members.DesignExome sequencing and ophthalmic clinical examination study.ParticipantsSix members from 2 consanguineous Jordanian families with IRD.MethodsOphthalmic examinations and whole-exome sequencing (WES) were performed to identify IRD-causing variants in affected individuals from each family, followed by segregation analysis of candidate variants in affected and unaffected family members by Sanger sequencing.ResultsWe identified 2 different homozygous deletion variants in CERKL in each family: a novel pathogenic variant, c.450_451delAT, and a known variant, c.1187_1188delTG. Both variants co-segregated with the disease in all affected family members. The resulting phenotypes further supported that CERKL is associated with cone–rod dystrophy (CRD) rather than retinitis pigmentosa (RP), as originally established.ConclusionOur study expands the genotypic spectra of CERKL variants, providing insights into the relevant pathogenesis of RP/CRD. We also confirm that the WES approach is a valuable tool for the molecular diagnosis of retinopathies. |
| |
Keywords: | Correspondence to Belal Azab, PhD, Cell Therapy Center, The University of Jordan, Amman 11942, Jordan, Abdalla Awidi, MD, Cell Therapy Center, The University of Jordan, Amman 11942, Jordan, |
本文献已被 ScienceDirect 等数据库收录! |
|